Making it in Manufacturing

What does it take to turn around a global antibiotic manufacturer and redefine its future in one of the toughest market environments in Europe?This week, in another episode of the Making It in Manufacturing Spotlight Series, hosted by @Thomas McMann we sit down with @Michael Kocher, CEO of @Xellia, who brings over two decades of leadership experience across global pharma and large-scale operations. With a career spanning senior roles in big-pharma and now leading a globally influential API manufacturer, Michael shares a remarkably honest look at the realities, decisions, and opportunities shaping Xellia today. In this episode, Michael covers:- Surprises from his first two years as CEO, including the talent, mindset, and culture he found inside Xellia.- His early strategic focuses, stabilising finances, divesting business operations, and rebuilding a sustainable foundation.- Xellia’s key differentiators, its portfolio of anti-infectives, their role in fighting severe infections and AMR.- The decision to close its Copenhagen manufacturing site over 8-10 years, why the long-term shift was necessary and how it impacts future manufacturing.- European policy and market pressures, reimbursement challenges, OPEX subsidies, and why reshoring isn’t realistic.- Future priorities, financial strengthening, product transfers, market-share growth, and new product launches.- Biggest opportunities ahead, expanding the fermentation-based API portfolio and doubling down on critical medicines. Full Podcast Be sure to check out this episode to hear Michael’s candid perspective on leadership, manufacturing, European policy, and what it truly takes to win in today’s API landscape.Follow ARTO:LinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.com/YouTube: https://www.youtube.com/@life_sciencesMichael KocherCEO at Xellia PharmaceuticalsLinkedIn: https://www.linkedin.com/in/michael-kocher-191863a/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/ Hosted on Acast. See acast.com/privacy for more information.

97% of our viewers don't realise they aren't subscribed, please double check, thank you!What does it really take to scale pharmaceutical manufacturing globally, without losing sight of patients?In this standout episode of Making It in Manufacturing, we sit down with Preben Haaning, Board Member at Xellia Pharmaceuticals, and a global pharmaceutical executive with 25+ years of experience spanning sales, finance, site leadership, and board-level strategy.Preben shares lessons from an extraordinary career: including his pivotal years at Novo Nordisk, where he helped scale global manufacturing networks and supported the early foundations of today’s GLP-1 supply chain.In this episode, Preben covers:How Xellia Pharmaceuticals is scaling critical anti-infectives while maintaining reliable global supplyHis unconventional journey from the military into life sciences leadership, and what it taught him about resilience and decision-makingReal-world examples of project success and failure, including moments where patient access was directly at riskWhat it’s like operating as a global pharmaceutical executive, managing multi-site, multi-culture manufacturing networksInside Novo Nordisk’s US expansion, including the launch of its first US-produced drug and early GLP-1 manufacturing challengesIf you’re working in pharmaceutical manufacturing, engineering, operations, or leadership, this is an episode packed with hard-won insight from the front lines.👉 Be sure to check out the full episode and subscribe for more conversations with the leaders shaping life-sciences manufacturing.Follow ARTOLinkedIn:   / artotalent  Spotify: https://open.spotify.com/show/0kEcRZO...Instagram: https://www.instagram.com/arto.talent...TikTok: https://www.tiktok.com/@artotalent?_t...Apple Podcasts: https://podcasts.apple.com/us/podcast...Website: https://arto-talent.comYoutube:    / @life_sciences  Preben HaaningBoard Member at Xellia PharmaceuticalsLinkedIn:   / preben-haaning-18a6193  Thomas McMannDirector - Contracts DivisionLinkedIn:   / thomas-mcmann-05540a10b  Timestamps:02:03 Xellia Pharmaceuticals11:07 From the Military to Life Sciences19:11 Project Success and Failure28:51 Global Pharmaceutical Executive46:41 Novo Nordisk Expansion of US Supply Hosted on Acast. See acast.com/privacy for more information.

What does it take to step into a publicly listed CDMO and immediately reposition it for growth in a shifting global market? At Mabion, it starts with people, scientific excellence and a clear commercial vision.This week on Making It In Manufacturing, Thomas McMann sat down with Gregor Kawaletz, CEO of Mabion, bringing over 20 years of experience in the CDMO space spanning leadership roles across NextPharma, Catalent and Recipharm. Now in the first month as CEO, Gregor shares why this move was about broader impact and how the organisation will be steered into its next phase.In this episode, Gregor covers:• The first month as CEO at @Mabion and why “every company is about people” • The transition from Chief Commercial Officer roles into a CEO position with responsibility for the full organisation • Growth priorities, pipeline confidence and an upcoming adjusted business model • The €500,000 innovation initiative and awarding @WPD for novel antibody drug conjugate programmes in oncology • Regulatory shifts in the biosimilar space and how reduced requirements are expanding patient access The conversation also explores operating in a more multipolar global environment and why CDMOs must move beyond traditional fee-for-service models toward deeper collaboration and network thinking.For professionals in biologics, biosimilars or CDMO partnerships, this episode offers strategic insight shaped by experience across NextPharma, Catalent, Recipharm and now at Mabion.Check out this episode to hear how scientific depth, commercial leadership and organisational alignment can reposition a CDMO for long-term success.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.com/Youtube: https://www.youtube.com/@life_sciencesGregor Kawaletz - CEO at MabionLinkedIn: https://www.linkedin.com/in/gregor-kawaletz-276a4830/Thomas McMann - Director At ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 First month as CEO at Mabion02:19 Two decades in the CDMO space including NextPharma, Catalent and Recipharm02:42 Moving from CCO to CEO05:10 Growth strategy and business model evolution06:57 €500k innovation award and WPD09:41 Biosimilars regulation and market access11:04 Navigating a multipolar global supply landscape12:47 Expanding Mabion’s future offering#MakingItInManufacturing #ARTOTalent #CDMO #Biologics #Biosimilars #LifeSciences #ManufacturingLeadership Hosted on Acast. See acast.com/privacy for more information.

What does it really take to build trust in pharmaceutical and biotech partnerships when timelines are tight, expectations are high, and the market never stands still?This week on Making It In Manufacturing, Tom McMann sat down with Alexander Schäfer, Business Development Manager, to unpack what strong execution, honest communication, and long-term thinking look like inside global contract packaging services.In this episode, Alexander shares insights from his work across European operations in pharmaceutical and biotech packaging, supporting everyone from early-stage virtual biotechs to established blue-chip pharma organisations. Speaking from the floor of CPHI, one of the industry’s most important global events, he breaks down how expectations shift across company sizes and why trust is earned through delivery, not promises.Throughout the conversation, Alexander references the realities of operating at scale within global packaging services, the importance of listening to market demand, and how investment decisions are shaped by customer needs and long-term industry trends.In this episode, Alexander Schäfer covers:• How servicing small biotechs versus large pharma companies requires different approaches to expectations and support (01:28)• Why trust in business development is built through execution, consistency, and reputation over time (03:12)• The importance of open communication and solution-led thinking when projects face challenges (04:24)• What skills matter most in business development, including listening, asking the right questions, and understanding customer pain points (06:29)• How major investments into packaging capacity, injectables, and device assembly are shaping the future of the industry (07:21)This conversation was recorded during CPHI, where industry leaders come together to discuss innovation, investment, and the future of pharmaceutical manufacturing. It offers a grounded look at how business development works behind the scenes in a highly regulated, fast-moving environment.If you are working in pharma, biotech, manufacturing, or commercial leadership, this episode offers practical insight into how long-term partnerships are built and sustained.Check out the full episode now.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.com/YouTube: https://www.youtube.com/@life_sciencesAlexander SchäferLinkedIn: https://www.linkedin.com/in/alexander-sch%C3%A4fer-4515a433/Tom McMannLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Introduction and context from CPHI00:54 Overview of European operations and contract packaging services01:28 Servicing biotech versus pharma clients03:12 Building trust through execution and reputation04:24 Managing challenges with open communication and solutions06:29 Essential skills for business development professionals07:21 Investment in injectables, devices, and future capacity10:25 Closing reflections#MakingItInManufacturing #ARTOTalent #PharmaManufacturing #Biotech #BusinessDevelopment #CPHI #ContractPackaging Hosted on Acast. See acast.com/privacy for more information.

The CDMO Changing the Game in Drug DeliveryThis week, in another episode of the Making it in Manufacturing Spotlight Series, we sit down with Ankit Gupta, CEO of Instapill, a company redefining oral drug delivery through freeze-dried, fast-dissolving tablets.With over 15 years of experience spanning investment banking, M&A, and leadership roles in pharmaceutical manufacturing, Ankit brings a sharp perspective on scaling, innovation, and sustainable differentiation.In this episode, Ankit covers:Instapill’s unique FDA-approved non-gelatin ODT technology and why it’s transforming patient outcomes in paediatrics and geriatrics.Scaling up manufacturing capacity in India and future expansion plans into the US, and how automation will maintain quality at scale.How digital transformation and AI are shaping pharmaceutical manufacturing, from paperless R&D to data-driven precision in production.What makes a CDMO attractive to investors, and how sustainable differentiation trumps trend-driven momentum.Lessons from M&A and investment banking, and how they inform his approach as a CEO leading growth in a competitive CDMO landscape.Be sure to check out this episode to hear how Instapill is not only innovating formulation, but reimagining the future of pharma manufacturing.To listen to (or watch) the full episode, search "Making it in Manufacturing Instapill" on your preferred streaming platform. Or, click on the first link in the comments below.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalent/Spotify: https://open.spotify.com/show/0kEcRZO...Instagram: https://www.instagram.com/arto.talent...TikTok: https://www.tiktok.com/@artotalent?_t...Apple Podcasts: https://podcasts.apple.com/us/podcast...Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesAnkit GuptaCEO at InstapillLinkedIn: https://www.linkedin.com/in/reachankit/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:11 Stand Out FDA Approval & Speed to Market08:00 Global Growth and Operations10:55 Insights & Leadership Takeaways Hosted on Acast. See acast.com/privacy for more information.

Continuous manufacturing is reshaping biologics - and today’s guest is one of the leaders driving that shift.This week, in another episode of the Making It in Manufacturing Spotlight Series, we sit down with Himanshu Gadgil, PhD, CEO of Enzene. With over a decade of experience spanning scientific innovation, biologics development & manufacturing, global expansion and CDMO leadership, Himanshu shares the story behind Enzene’s rise from a small R&D biotech in India to a rapidly scaling global CIDMO with newly established US manufacturing.In this episode, Himanshu covers:- How Enzene built and evolved its first-in-class, fully-connected continuous manufacturing platform, EnzeneX - including initial failures shaped breakthrough innovation.- Why fully-connected continuous manufacturing™ is a cost and efficiency game-changer for biologics.- The regulatory and operational challenges of scaling this technology - and how Enzene approached India-to-US expansion.- Leadership lessons in his progression from scientist to CEO, including culture, resilience, and recognising that success depends on the combination of transformative innovation with a unique values/mission-driven approach to the way business gets done.- The future of biomanufacturing - from localisation and personalised production to fully automated, analytics-driven systems.Be sure to check out this episode to hear how Enzene is redefining what a modern CDMO can be.To listen to (or watch) the full episode, search "Making it in Manufacturing Enzene" on your preferred streaming platform, or click on the first link in the comments below.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesHimanshu GadgilCEO of EnzeneLinkedIn: https://www.linkedin.com/in/himanshu-gadgil-3326307/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:10 Enzene's Vision04:10 Building & Scaling a Global Platform07:51 Enzene's Competitive Edge14:56 The Future of CDMO's21:01 Vision for Enzene's Future Growth Hosted on Acast. See acast.com/privacy for more information.

The CDMO everyone’s suddenly talking about, and the CEO taking it to the next level.This week, in another episode of the Making It in Manufacturing Spotlight Series, hosted by Thomas McMann, we sit down with Dirk T. Lange, CEO at Pyramid Pharma Services. With 30 years of experience across drug-substance and drug-product CDMOs, global operations, outsourcing leadership, and life-science services, spanning Rentschler, KBI Biopharma, Novartis, Sandoz, and more, Dirk brings a rare dual-lens perspective from both the provider and sponsor side.In this episode, Dirk covers:- A full overview of Pyramid Pharma Services, a 37-year-old CDMO with an exceptionally broad drug-product offering from clinical to commercial supply.- Key data behind Pyramid’s under-the-radar growth, including 15 successful FDA inspections, a strong legacy of quality, and decades of organic expansion driven by long-term customer partnerships.- Why they’re doubling their fill–finish capabilities, including the strategic drivers, client demand, and the transition from clinical-scale to high-speed commercial lines.- The operational realities of scaling, from maintaining culture to onboarding new teams, strengthening processes, and preserving execution excellence during rapid growth.- How Pyramid positions itself as an enabler in the supply chain, supporting customers from early development through long-term commercial supply.Be sure to check out this episode, a deep dive into what it really takes to scale a legacy CDMO while protecting quality, culture, and customer trust.To listen to (or watch) the full episode, search "Making it in Manufacturing Pyramid Pharma" on your preferred streaming platform, or click on the first link in the comments below.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesDirk T. LangeCEO at Pyramid Pharma ServicesLinkedIn: https://www.linkedin.com/in/langedirk/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:11 Pyramid Overview01:41 Key Data03:46 Doubling Fill Finish Capabilities05:38 Growth Challenges Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Making It in Manufacturing Spotlight Series, we sit down with Raj Puri, Chief Commercial Officer at Argonaut Manufacturing Services. With over 12 months in the CCO role and extensive experience across the CDMO space, Raj brings insight from leading business development, project management, and commercial strategy across both life science/diagnostics and aseptic drug-product services.In this episode, Raj covers:- Why Argonaut chooses to support “N of 1” programmes, and the cultural impact of delivering life-saving therapies for single-patient treatments.- The operational challenges of ultra-high-value API filling, and how Argonaut minimises line losses for rare-disease therapies.- The company’s evolution, from diagnostics to becoming a major player in small- to mid-scale aseptic drug-product manufacturing.- How Argonaut’s new $45M facility and commercial-scale filling line will transform output, enable prefilled syringes/cartridges, and support global demand.- The realities of scaling a CDMO, including hiring, maintaining culture, preparing for FDA pre-approval inspection, and setting long-term strategy for future capabilities.Be sure to check out this episode to hear Raj’s candid take on growth, culture, and the future of drug-product manufacturing.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesRaj PuriCCO at Argonaut Manufacturing ServicesLinkedIn: https://www.linkedin.com/in/raj-puri-3137665/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:10 Stepping Into The Role & Early Lessons04:03 Scaling Smart: Challenges and Capabilities09:07 Culture, Talent & The Future Hosted on Acast. See acast.com/privacy for more information.

The CDMO Changing the Game in Drug DeliveryThis week, in another episode of the Making it in Manufacturing Spotlight Series, we sit down with Ankit Gupta, CEO of Instapill, a company redefining oral drug delivery through freeze-dried, fast-dissolving tablets. With over 15 years of experience spanning investment banking, M&A, and leadership roles in pharmaceutical manufacturing, Ankit brings a sharp perspective on scaling, innovation, and sustainable differentiation.In this episode, Ankit covers:- Instapill’s unique FDA-approved non-gelatin ODT technology and why it’s transforming patient outcomes in paediatrics and geriatrics.- Scaling up manufacturing capacity in India and future expansion plans into the US, and how automation will maintain quality at scale.- How digital transformation and AI are shaping pharmaceutical manufacturing, from paperless R&D to data-driven precision in production.- What makes a CDMO attractive to investors, and how sustainable differentiation trumps trend-driven momentum.- Lessons from M&A and investment banking, and how they inform his approach as a CEO leading growth in a competitive CDMO landscape.Be sure to check out this episode to hear how Instapill is not only innovating formulation, but reimagining the future of pharma manufacturing.To listen to (or watch) the full episode, search "Making it in Manufacturing Instapill" on your preferred streaming platform. Or, click on the first link in the comments below.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesAnkit GuptaCEO at InstapillLinkedIn: https://www.linkedin.com/in/reachankit/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:11 Stand Out FDA Approval & Speed to Market08:00 Global Growth and Operations10:55 Insights & Leadership Takeaways Hosted on Acast. See acast.com/privacy for more information.

What does it really take to build one of Europe’s fastest-growing drug-product CDMOs, and do it with scientific precision, culture-first leadership, and a B-Corp mindset?This week, in another episode of the Making It in Manufacturing Spotlight Series, we sit down with Hanns-Christian Mahler, CEO & Founder of ten23.With over 20 years of experience spanning senior roles at Merck, Roche, biopharma development, drug-product strategy, and CDMO leadership, Hanns-Christian brings a rare blend of scientific rigour, sustainability vision, and people-centric leadership.In this episode, Hanns-Christian covers:- The origin story of ten23 and why he left big pharma to challenge the CDMO status quo with ten23- Why ten23 leads with partnership - not execution - and how “asking better questions” is their competitive edge ten23- ten23’s rapid growth journey: new filling lines, site expansion, headcount growth, and strategic partnerships, like with BD- The culture behind the company: transparency, autonomy, values-led leadership, and building a truly learning organisation at ten23- The future of CDMOs: AI adoption with intention, sustainability as a scientific discipline, and what’s next for ten23’s global footprint- Hanns-Christian also speaks about his partnerships with sustainability-focused companies such as Lio, led by CEO Vladimir Keil, highlighting how these collaborations help drive more responsible and efficient operations.If you want a masterclass in modern CDMO leadership, rooted in science, innovation, and purpose, this is the episode to watch.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesHanns-Christian MahlerCEO at ten23LinkedIn: https://www.linkedin.com/in/hanns-christian-mahler/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings & ten2308:18 Challenges with Scaling14:29 Culture & Leadership Style20:00 Scientific Rigour vs Sustainability26:07 Challenges with Geopolitical Issues29:13 The Future & AI Hosted on Acast. See acast.com/privacy for more information.

If you're leading in pharma, biotech, or manufacturing, this is essential listening.This week, we kick off Season 2 of Making It In Manufacturing with a heavyweight guest: J.D. Mowery, Division President, CDMO at Bora Pharmaceuticals. With more than 25 years of experience across the biopharmaceutical and CDMO sectors, J.D. brings a proven track record of building high-performing teams, scaling operations, and driving innovation at every stage of the drug development lifecycle. He has held impactful leadership roles at industry leaders such as Genentech, Lonza, and JSR Life Sciences, and most recently served as CEO of KBI Biopharma. His expertise spans operations, manufacturing, technology transfer, facility construction, and business development, with a global perspective shaped by work across North America, Europe, and Asia. J.D. is known for his hands-on leadership style, commitment to operational excellence, and passion for building strong, collaborative cultures.In this episode, J.D. unpacks:- Smart integration and scaling: Integration and scaling of sites post-acquisition- Why quality is still the sharpest competitive edge- What it means to partner with purpose in today’s pharma landscape- Where CDMOs are headed next - and how AI is shaping that directionIf you're in a leadership role within pharma or biotech, this is the episode you’ll want your entire team to hear.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ngInstagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesJ.D. MoweryDivision President - CDMOLinkedIn: https://www.linkedin.com/in/jdmowery/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Filling Sites & Scaling Smartly06:38 Quality as a Differentiator13:30 Partnering with Purpose17:19 The Future of CDMOs and AI Hosted on Acast. See acast.com/privacy for more information.

In this episode, we’re joined by Abbas Hussain, an internationally recognised engineering leader and current Projects & Engineering Manager at EUROAPI.He oversees the end-to-end design and delivery of GMP-compliant manufacturing facilities for APIs, peptides, and oligonucleotides, combining technical depth with strategic execution.With over 20 years of experience in pharmaceutical and biotech engineering, Abbas has led major capital projects across global markets.His career includes an extensive tenure at Sanofi, where he held senior roles in process engineering, project delivery, and technology transfer.A regular speaker on the international stage, Abbas most recently represented EUROAPI at the 2025 ISPE Europe Annual Conference in London.In this episode, we cover a range of topics including Culture, CAPEX, Project Planning & Delays, Sustainability, AI, Quickfire Questions and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in the manufacturing and engineering space.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO Recruitment\Abbas HussainProjects & Engineering Manager at EUROAPI.LinkedIn: https://www.linkedin.com/in/abbas-sayyed-028a7812/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings08:31 Culture Differences16:58 CAPEX, Project Planning & Delays30:42 Sustainability36:54 AI & Rounding Up#MakingItInManufacturing #ARTOTalent #ManufacturingAndEngineering #ISPE #AI #OPEX #CDMOS #DataIntegrity #Auditing #CSV #CAPEX #Sustainability Hosted on Acast. See acast.com/privacy for more information.

In this episode, we feature Michael Vrijs, a well-recognised expert in cleaning validation and biopharma manufacturing, known for turning complex compliance into practical strategy:Currently Manager, Manufacturing Technology at Incyte (since 2021), leading cleaning process development and validation at Incyte’s biologics manufacturing site in Switzerland.Brings nearly 20 years of experience in biopharma manufacturing, specialising in cleaning processes, cleaning validation, tech transfer, continuous improvement, and CAPEX in multi‑product environments.Spent over a decade as a consultant - serving as Senior Consultant with GxP Consulting Switzerland, and holding senior C&Q/validation roles at Novartis, MSD, Biogen, Pfizer, and Dako.A recognised ISPE speaker, Michael shares his expertise on large stages including ISPE conferences, engaging global audiences on biopharma manufacturing best practices.In this episode, we cover a range of topics including Michael’s Career Beginnings, Cleaning and Validation, Common Mistakes Businesses make, Auditor Handling, Advice for young Engineers, and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in the manufacturing and engineering space.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentMichael VrijsManager Manufacturing TechnologyLinkedIn: https://www.linkedin.com/in/michael-vrijs-84b97940/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings06:09 Cleaning / Validation13:53 Common Mistakes / Auditor Handling22:11 Advice for Engineers #MakingItInManufacturing #ARTOTalent #ManufacturingAndEngineering #ISPE #AI #OPEX #CDMOS #DataIntegrity #Auditing #CSV, CAPEX, Sustainability #Cleaning #Validation Hosted on Acast. See acast.com/privacy for more information.

In this episode, we are joined by Carsten Jasper, a globally recognised leader specialising in pharmaceutical quality, regulatory compliance, and digital transformation within life sciences.Carsten leads Quality & Compliance within Charles River’s R&D division, where he oversees risk management and the validation of regulated systems.With 20 years of experience across in-vitro diagnostics, aseptic manufacturing, and total quality management, he brings deep regulatory and operational expertise.He also runs Jasper Consulting and contributes to PTS Training Service, developing AI-powered tools such as VR/AR simulations and digital twins for cleanroom training.Previously, he held senior roles in diagnostics and chemical technology and is a regular industry speaker, most recently presenting on AI in cleanroom design at a leading Life Sciences engineering conference.In this episode, we discuss a range of topics including CSV Validation, Risk Management, Data Integrity, AI, Auditing, Advice for Candidates and more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in the manufacturing and engineering space.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentCarsten JasperSenior Director, QRM and CQV (R&D)LinkedIn: https://www.linkedin.com/in/carsten-jasper-59189982/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings10:09 CSV Validation & Risk Management 15:13 Data Integrity & AI23:53 Auditing31:54 Rounding Up#MakingItInManufacturing #ARTOTalent #ManufacturingAndEngineering #ISPE #AI #OPEX #CDMOS #DataIntegrity #Auditing #CSV Hosted on Acast. See acast.com/privacy for more information.

In this episode of Making It In Manufacturing, we speak with Simon Adams, a seasoned advisor and founder of Adams Bio Consulting Ltd, about the evolving demands of leadership in the Life Sciences sector.He is the Founder and Principal at Adams Bio Consulting Ltd, a leadership consultancy dedicated to the Life Sciences industry.With 25+ years of experience, he specialises in organisational transformation and leadership development in high-stakes environments.His career includes Pharma and Biopharma as well as the broader life sciences remit with previous roles at VP and Group Director levels in Operations, Leadership and Operational Excellence providing services in the UK and extensively across the continent.In this episode, we discuss a range of topics including aseptic compounding, CDMOs - when, where and why use them, OPEX , leadership, cross functional management and more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in the manufacturing and engineering space.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentSimon AdamsFounder and Principal at Adams Bio Consulting LtdLinkedIn: https://www.linkedin.com/in/simon-adams-86005710/Thomas McMannDirector - Contracts Division at ARTOLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings07:18 Aseptic Compounding18:50 CDMOs28:19 OPEX45:44 Leadership & Management#MakingItInManufacturing #ARTOTalent #ManufacturingAndEngineering #ISPE #AI #OPEX #CDMOS Hosted on Acast. See acast.com/privacy for more information.

In this episode, we feature Hazem Eleskandarani, P.E., PMP, a distinguished leader in pharmaceutical engineering and quality assurance: Hazem leads the Global Quality Engineering team at CSL Behring, a global biopharmaceutical company specialising in plasma-derived therapies and he holds a Master's degree in Mechanical Engineering from the University of Utah.30+ years of global experience. Hazem has expertise in manufacturing, process engineering, quality engineering, technology management, and project engineering.His career includes significant roles at Fluor Daniel, Jacobs Engineering, Merck, and Johnson & Johnson, where he led global commissioning and qualification initiatives, and is internationally recognised for his contributions to pharmaceutical engineering, including co-authoring the ISPE Baseline Guide 5.Hazem has been a featured speaker at the 2025 ISPE Europe Annual Conference, discussing topics such as risk-based qualification and good engineering practices.In this episode, we discuss a range of topics including risk management, AI, project acceleration and its drawbacks, traits that make a great CQV engineer, common mistakes, cross functional management, as well as tips when it comes to inspectors visiting a new site. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in the manufacturing and engineering space. Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentHazem Eleskandarani Senior Director, Global Quality EngineeringLinkedIn: https://www.linkedin.com/in/hazem-eleskandarani-p-e-pmp-47705842/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings12:40 Project Acceleration & Drawbacks20:36 Risk Management & Project Delays31:45 AI & Leadership38:41 Cross Functional Managing #MakingItInManufacturing #ARTOTalent #ManufacturingAndEngineering #ISPE #AI Hosted on Acast. See acast.com/privacy for more information.

In this episode, we feature Hilary Mills-Baker, a distinguished expert in process automation and computer systems validation within the life sciences sector:Hilary serves as the Chair of the UK GAMP Community of Practice, where she leads initiatives to advance good automated manufacturing practices in the pharmaceutical industry, and was previously the European Quality and Validation Manager at Emerson Automation Solutions.35+ years in process automation engineering and more than 20 years in the life sciences sector, Hilary has extensive experience in computer systems validation and quality assurance, as well as holding a BSc and an MEng in Engineering from Brunel University London.Hilary is internationally recognised for her contributions to the ISPE GAMP®5 good practice guides, including co-leading the update of the Process Control Systems Good Practice Guide following the publication of GAMP®5 2nd Edition.Hilary was a featured speaker at the 2025 ISPE Europe Annual Conference, where she discussed the integration of digitalised project execution tools in automation and AI-enabled processes.In this episode, we discuss a range of topics including DeltaV, automation, Gender Diversity within Manufacturing and Engineering, GAMP, the ISPE conference, as well as AI and CyberSecurity and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in the manufacturing and engineering space.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentHilary Mills-BakerEuropean Manager of Quality and ValidationLinkedIn: https://www.linkedin.com/in/hilarymillsbaker/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:00 Career Beginnings12:03 DeltaV & Automation16:40 AI & Cyber Security22:31 Gender Diversity in M&E28:42 GAMP and ISPE#MakingItInManufacturing #ARTOTalent #ManufacturingAndEngineering #ISPE #AI Hosted on Acast. See acast.com/privacy for more information.

Hosted by Thomas McMann Making It In Manufacturing is ARTO's new in-person podcast series, spotlighting the leaders shaping the future of manufacturing and engineering.Each episode dives into the careers, decisions, and defining moments of industry mainstays - revealing the stories and insights behind real-world impact within the manufacturing and engineering space.If you're a leader in the space - or aspiring to be - this podcast is a must watch. Episodes are available on YouTube, Spotify, Apple Podcasts and all major platforms. Hosted on Acast. See acast.com/privacy for more information.